Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydrotriazolopyridine compounds as selective MGLU5 receptor potentiators useful for the treatment of schizophrenia

Tetrahydrotriazolopyridine compounds as selective MGLU5 receptor potentiators useful for the treatment of schizophrenia

US Patent 8592590 · Granted Nov 26, 2013

Estimated economic value: $96,858,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds active towards nuclear receptors2025
Compounds active towards nuclear receptors2023
Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agon2016
MGlu 2/3 agonists2013
MGLU2 agonists2012
MGLU2 agonists2012
Modulators of peroxisome proliferator activated receptors2007
Modulators of acetylcholine receptors2006